Relcovaptan
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Relcovaptan (SR-49059) is a non-peptide vasopressin receptor antagonist, selective for the V1A subtype.[1] It has shown positive initial results for the treatment of Raynaud syndrome and dysmenorrhoea, and as a tocolytic,[2] although it is not yet approved for clinical use.
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".